🇺🇸

🇺🇸

Login

Editas Medicine Aktie News & Pressemeldungen

Editas Medicine Eulerpool News

10/5/2024, 6:17:42 PM

Editas Medicine sichert sich 57 Millionen Dollar durch strategischen Lizenzverkauf

10/22/2024, 8:42:52 PM

Editas und Genevant: Partnerschaft für die Zukunft der Geneditierung

12/13/2024, 4:27:47 AM

Editas Medicine plant drastische Umstrukturierung und fokussiert auf In-vivo Gentherapien

12/13/2024, 1:05:31 PM

Editas Medicine richtet strategisch neu aus: Fokus auf In-vivo-Geneditierung

1

1

Editas Medicine Stock News

Editas Medicine is being monitored by journalists and investors worldwide. We gather the latest Editas Medicine news here.

September 30 ·
Yahoo
Institutions profited after Editas Medicine, Inc.'s (NASDAQ:EDIT) market cap rose US$47m last week but individual investors profited the most
September 29 ·
Yahoo
Editas Medicine Inc. (EDIT) Confirms EDT-401 as Lead Vivo Program
September 11 ·
Yahoo
Why Is Editas (EDIT) Down 16.9% Since Last Earnings Report?
September 3 ·
Yahoo
Editas Nominates EDIT-401 as Lead In Vivo Therapy for High Cholesterol
September 2 ·
Yahoo
Editas Medicine Nominates EDIT-401, an LDLR-Targeted Medicine, as Lead In Vivo Development Candidate
September 2 ·
SeekingAlpha
Editas Medicine, Inc. (EDIT) Lead In Vivo Development Candidate Webinar Call
September 2 ·
SeekingAlpha
Editas Medicine, Inc. (EDIT) Lead In Vivo Development Candidate Webinar (Transcript)
September 2 ·
SeekingAlpha
Editas Medicine, Inc. - Special Call
September 2 ·
Yahoo
Can Editas Medicine (NASDAQ:EDIT) Afford To Invest In Growth?
September 2 ·
SeekingAlpha
Satellos Bioscience: Promising Novel Treatment For Duchenne Muscular Dystrophy

1

2

1

2

Editas Medicine Stock Press Releases

Editas Medicine regularly publishes news on the company's website that are relevant for investors.

Discover undervalued stocks with Eulerpool.

Subscribe for $2